KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) EPS (Weighted Average and Diluted) (2016 - 2025)

CareDx's EPS (Weighted Average and Diluted) history spans 13 years, with the latest figure at -$0.08 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 105.63% year-over-year to -$0.08; the TTM value through Dec 2025 reached -$0.4, down 153.33%, while the annual FY2025 figure was -$0.4, 143.01% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.08 at CareDx, down from $0.03 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.42 in Q4 2024 and bottomed at -$2.2 in Q4 2023.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.27 (2021), against an average of -$0.26.
  • The largest annual shift saw EPS (Weighted Average and Diluted) tumbled 3600.0% in 2022 before it skyrocketed 164.55% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.31 in 2021, then decreased by 12.9% to -$0.35 in 2022, then tumbled by 528.57% to -$2.2 in 2023, then skyrocketed by 164.55% to $1.42 in 2024, then tumbled by 105.63% to -$0.08 in 2025.
  • Per Business Quant, the three most recent readings for CDNA's EPS (Weighted Average and Diluted) are -$0.08 (Q4 2025), $0.03 (Q3 2025), and -$0.16 (Q2 2025).